Interrogating IDH Mutation in Brain Tumor: Magnetic Resonance and Hyperpolarization

Keywords

Primary care, Mental health, Medicine, Primary health care, Mental health care

References

• Automatic quantitation of localized in vivo 1H spectra with LCModelStephen W. Provencher — 2001
• Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1αShimin Zhao, Yan Lin, Wei Xu — 2009
• Detection of 2-Hydroxyglutarate in IDH-mutated Glioma Patients by Spectral-editing and 2D Correlation Magnetic Resonance SpectroscopyOvidiu C. Andronesi, Grace S. Kim, Elizabeth R. Gerstner — 2012
• Non-invasive in vivo assessment of IDH1 mutational status in gliomaMyriam M. Chaumeil, Peder E. Z. Larson, Hikari A. I. Yoshihara — 2013
• 1H and 13C NMR study of 2‐hydroxyglutaric acid and its lactoneDominika Bal, Adam Gryff‐Keller — 2002
• Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1-13C]pyruvate and 13C magnetic resonance spectroscopic imagingSam E. Day, Mikko I. Kettunen, Murali Cherukuri — 2010
• 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated glioma patientsChangho Choi, Sandeep Ganji, Ralph J. DeBerardinis — 2012
• Metabolite Kinetics in C6 Rat Glioma Model Using MRSI of Hyperpolarized [1-13C]PyruvateJae Mo Park, Sonal Josan, Taichang Jang — 2012
• BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1Martje Tönjes, Sebastian Barbus, Yoon Jung Park — 2013
• Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in gliomaMyriam M. Chaumeil, Peder E. Z. Larson, Sarah M. Woods — 2014
• Reduced phosphocholine and hyperpolarized lactate provide magnetic resonance biomarkers of PI3K/Akt/mTOR inhibition in glioblastoma.Humsa S. Venkatesh, Myriam M. Chaumeil, Christopher Ward — 2012
• Changes in pyruvate metabolism detected by magnetic resonance imaging are linked to DNA damage and serve as a sensor of temozolomide response in glioblastoma cellsIlwoo Park, Joydeep Mukherjee, Motokazu Ito — 2014
• Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors.I. Park, Peder E. Z. Larson, Matthew L. Zierhut — 2010
• Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.Macarena I. de la Fuente, Robert J. Young, Jennifer Rubel — 2016
• Hyperpolarized 13C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoringMyriam M. Chaumeil, Marina Radoul, Chloé Najac — 2016
• Non-invasive detection of 2-hydroxyglutarate in IDH-mutated gliomas using two-dimensional localized correlation spectroscopy (2D L-COSY) at 7 TeslaGaurav Verma, Suyash Mohan, MacLean P. Nasrallah — 2016
• Interrogating Metabolism in Brain CancerTravis C. Salzillo, Jingzhe Hu, Linda Nguyen — 2016
• Using thematic analysis in psychologyVirginia Braun, Victoria Clarke — 2006
• Health, United States, 2011: With Special feature on Socioeconomic Status and Health2012
• IDH1 and IDH2 mutations in gliomas.F. Ducray, Y. Marie, M. Sanson — 2009

Cited by

• Reliable diagnosis of IDH-mutant glioblastoma by 2-hydroxyglutarate detection: a study by 3-T magnetic resonance spectroscopyManabu Natsumeda, Kunio Motohashi, Hironaka Igarashi — 2018
• Advances and Challenges in Assessing 2-Hydroxyglutarate in Gliomas by Magnetic Resonance Spectroscopy: A Short ReviewManabu Natsumeda, Hironaka Igarashi, Kunio Motohashi — 2018
• Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic ResonanceTravis C. Salzillo, Vimbai Mawoneke, Joseph Weygand — 2021
• In vivo brain MR spectroscopy in gliomas: clinical and pre-clinical chancesFrancesco Padelli, Federica Mazzi, Alessandra Erbetta — 2022
• Magnetic Resonance Imaging of Primary Adult Brain Tumors: State of the Art and Future PerspectivesMatia Martucci, Rosellina Russo, Francesco Schimperna — 2023

Related papers

• Integration of Mental and Behavioral Health in Pediatric Health Care ClinicsTonya Cross Hansel, Glenn E. Rohrer, Joy D. Osofsky — 2017
• Knowledge of and Attitudes Toward Mental Illness Among Primary Care Providers in Saint Vincent and the GrenadinesRachel A. Winer, Amrie Morris-Patterson, Ynolde Smart — 2013
• Health care practitioners' perceptions of public mental health care in the Eastern Cape, South AfricaDalena van Rooyen, Kegan Topper, David Morton — 2014
• Technology Use in Rural Appalachia: A Pilot Study of the Implications for Pediatric Behavioral HealthCourtney Lilly — 2013
• 2.47 MENTAL HEALTH AND SUBSTANCE USE SCREENING AND TREATMENT PRACTICES IN COLORADO’S SCHOOL-BASED HEALTH CENTERSSteven A. Solomon, Paula Riggs, Jesse Hinckley — 2019
• The association between enrollment in Maryland’s behavioral health homes and outpatient mental health service utilizationRachel Presskreischer, Alene Kennedy‐Hendricks, Sachini Bandara — 2021
• Barriers and facilitators to mental health help-seeking among older adults in The Villages, Florida: A Qualitative StudySarah Fishleder — 2015
• Mental health care of black clients in two types of healthcare organizationsGlenda L. Harris, Maxine Springer Stern — 1988